Ming-Huang Chen

发表

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma

Yan-Shen Shan, Chin-Fu Hsiao, Tsang-Wu Liu, 2016, Medicine.

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

Chih-Hsien Chang, Wen-Sheng Huang, Gann Ting, 2019, EJNMMI Research.

C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis

Yi-Chen Yeh, Chung-Pin Li, Ling-Ya Chiu, 2017, The American journal of surgical pathology.

In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result.

Chi-Ying F. Huang, Chi-Ying F Huang, Ming-Huang Chen, 2013, Gene.

Analysis of Protein-Protein Interactions in Cross-talk Pathways Reveals CRKL Protein as a Novel Prognostic Marker in Hepatocellular Carcinoma*

Tzu-Chi Chen, Cheng-Yan Kao, Chi-Ying F. Huang, 2013, Molecular & Cellular Proteomics.

The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells

Wen-Chun Tsai, Chun-Teng Huang, Pei-Yi Chu, 2017, Experimental &Molecular Medicine.

Transcriptome analysis and prognosis of ALDH isoforms in human cancer

Chi-Ying F. Huang, Daria Mochly-Rosen, Hsueh-Ju Lu, 2018, Scientific Reports.

Gene expression‐based chemical genomics identifies heat‐shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma

Chi-Ying F. Huang, Kun-Ju Lin, Chi-Ying F Huang, 2013, Cancer.

A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.

Chi-Tung Cheng, Yen-Yang Chen, Tse-Ching Chen, 2016, Anticancer research.

Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma

Cheng-Yan Kao, Chi-Ying F. Huang, Chun-Nan Hsu, 2011, PloS one.